Nano way to ease hepatitis fight

In a major scientific breakthrough, doctors at AIIMS claim to have successfully tested a new drug delivery system based on nanotechnology to replace injectable vaccination for Hepatitis B with oral dosage . Lead researcher A K Dinda told TOI that the system had been tested successfully on animals and human trials would be completed by 2021.”People will not require multiple injections for Hepatitis B if this trial succeeds on humans. One oral dose will be enough,” Dr Dinda said. He said the technology platform could also be used for vaccine development for TB and other viral infections. Vaccines contain a small amount of the antigen, or parts of the germs that cause disease, which are either killed or weakened so that they can’t cause illness. When one is vaccinated, the body’s immune system reacts by creating antibodies against the germ, thus, helping it prepare to fight when the real disease attacks. Dr...